University Of Gothenburg
- Address
- P. O. Box 100, 405 30 Gothenburg, Sweden
University Of Gothenburg
The University of Gothenburg is engaged in advanced clinical research focused on gynecological oncology and innovative treatment approaches for rare cancers. The center demonstrates particular expertise in developing sentinel lymph node-based treatment strategies that aim to reduce surgical morbidity while maintaining oncologic safety in early-stage cancer patients.
- Vulvar cancer surgical management and treatment optimization
- Sentinel lymph node biopsy techniques in gynecologic malignancies
- Chemoradiation therapy as an alternative to conventional lymphadenectomy
The research center is particularly focused on investigating less invasive therapeutic approaches for early-stage vulvar cancer, exploring whether targeted chemoradiation can safely replace more extensive surgical procedures. This work represents a significant advancement in personalized cancer care, aiming to improve patient outcomes and quality of life while maintaining effective disease control in this challenging patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Of Gothenburg
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase II Study on the Efficacy of Chemoradiation with Cisplatin and Carboplatin in Early-Stage Vulvar Cancer with Sentinel Lymph Node Macrometastasis | Universitair Medisch Centrum Groningen | Phase II | Recruiting | Nov 2020 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 1 | Unknown | 2020-11-19 | 2020-11-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.